Wilson Sonsini and Attorneys Recognized in 2022 Edition of LMG Life Sciences
LMG Life Sciences recognized several Wilson Sonsini practices and 16 of its attorneys in the 2022 edition of its guide, which identifies and ranks the leading law firms and individuals in the life sciences industry.
The firm is ranked in the following categories: Corporate, Licensing & Collaboration, Venture Capital, Patent Strategy & Management, Patent Prosecution, Patent Litigation, and Hatch-Waxman Patent Litigation.
Additionally, the following attorneys were recognized as 2022 "Life Sciences Stars":
On September 8, the firm garnered several honors at the 2022 LMG Life Sciences Americas Awards, including “Hatch-Waxman Litigation Firm of the Year – Generic,” “Hatch-Waxman Impact Cases of the Year” for its work on Celgene v. Mylan (Federal Circuit, 2021), “Patent Impact Cases of the Year” for its work on ModernaTx v. Arbutus (Federal Circuit, 2021), and “Impact Deals of the Year – United States” for its role in Sanofi’s $6.15 billion collaboration with IGM Biosciences. Additionally, partner Michael Rosato was named “Post-Grant Proceedings Attorney of the Year.”
LMG Life Sciences conducts a review of interviews and surveys completed by individuals active in the life sciences industry to help inform the research process, in addition to reviewing public information.
For more information, please see LMG Life Sciences' online version of the guide.